 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Tetraphase Pharmaceuticals
TTPH
Conference date: March 12, 2020 press release only
Tetraphase: Add To Watch List On Potential Antibiotic Sales [September 19, 2019 at Seeking Alpha]
Biotech Bargain Basement: Tetraphase [January 2, 2019 at Seeking Alpha]
Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech [May 23, 2018 at Seeking Alpha]
Tetraphase Pharmaceuticals Trial Failure May Mask Value [February 27, 2018 at Seeking Alpha]
| 2019 | |||
| Tetraphase Pharmaceuticals Q1 2019 |
Tetraphase Pharmaceuticals Q2 2019 |
Tetraphase Pharmaceuticals Q3 2019 |
Tetraphase Pharmaceuticals Q4 2019 |
| May 8, 2019 | August 8, 2019 | Nov. 12, 2019 | Mar. 12, 2020 |
2018 |
|||
| Tetraphase Pharmaceuticals Q4 2018 |
|||
May 3, 2018 |
Aug. 2, 2018 |
Nov. 8, 2018 |
Mar. 14, 2019 |
Tetraphase Pharmaceuticals (TTPH) is a clinical-stage biotechnology company specializing in multidrug-resistant antibiotic therapies.
Tetraphase Pharmaceutical web site
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMD |
| AMGN |
| BIIB |
| BMY |
| CLDX |
| CLSN |
| EPZM |
| GILD |
| GLYC |
| INO |
| INTC |
| ISRG |
| MCHP |
| MYL. |
| PLX |
| REGN |
| SGEN |
| SYRS |
| VBLT |
| VSTM |
| XLNX |
| XLRN |
| div> |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2020 William P. Meyers